Healthcare
The 6 Forces Transforming the Future of Healthcare
The 6 Forces Transforming the Future of Healthcare
Disruptive technologies are advancing healthcare at an extraordinary pace.
By 2020, there will be 50 billion devices connected to the internet, and many of these devices will be tracking the health data of individuals. This will empower consumers in an exciting way, but it will also fundamentally shift how healthcare companies work and interact with their customers.
Today’s infographic comes to us from Publicis Health and it is the introduction to a seven-part series about the future of healthcare, and how companies will have to adapt to stay relevant.
The Changing Customer
The smartphone boom has changed the consumer experience in practically every industry, and it is now cascading into the healthcare market:
Commoditized
76% of consumers expect pharma/healthcare providers to provide services that help them manage their health.
Connected
59% of consumers expect their healthcare customer services to be as good as Amazon’s.
Quantified
76% of consumers expect pharma/healthcare to understand their individual needs.
In other words, the traditional healthcare model no longer aligns with the consumer mindset.
The Six Forces
Publicis Health, a global leader in health, has identified six transformative forces that healthcare companies must address to gain a competitive edge:
1. Data Activation
Data reveals truths. A robust data strategy fundamentally shifts how company manages their brands.
2. Workflow-Empowered Solutions
The patient experience will be at the center of a seamlessly connected workflow of information, with integrated electronic health records (EHR) that document more than just visits to the doctor. The proliferation of EHR opens new opportunities to service healthcare professionals and patients.
3. Content Strategy
Consumers want their healthcare information and insights delivered in a personalized, engaging, accessible, and dynamic format.
4. Intelligence Services
Consumers want the healthcare industry to “find, know, and help” them, using past behaviors and AI to anticipate their current and future needs.
5. Clinical Trial Recruitment
Finding the right patients remains a major challenge for pharma. New technologies and patient engagement strategies are greatly reducing the time and inefficiencies of clinical trial recruitment.
6. Sales Model Transformation
As AI takes hold and directs more automated Rx decisions, it will be more than just about relationships but also about relevant skills to make use of the new tools, while preserving the need for human touch.
Together, these forces build the transformative foundation to better performance, customer experience, and health outcomes.
This is part one of a seven part series. Stay tuned by subscribing to Visual Capitalist for free, as we go into these six forces in more detail in the future.
Healthcare
Innovation in Virology: Vaccines and Antivirals
Vaccine development has grown six-fold since 1995. Learn how virology, the study of viruses, is driving innovation in the healthcare industry.

Innovation in Virology: Vaccines and Antivirals
The COVID-19 pandemic affected millions of people worldwide and brought renewed focus to virology—the study of viruses.
However, impact made by viruses extends far beyond the SARS-CoV-2 virus that causes COVID-19. There are 24 viruses that have each infected more than 80 million people globally, from hepatitis to influenza.
In this graphic from MSCI, we uncover innovation in vaccines and antivirals and the related market opportunities.
What is a Virus?
A virus is a microscopic infectious agent that replicates within living cells. It may cause disease in its host. New viruses can emerge at any time as a result of mutation, or when viruses transfer from animals to humans.
Through virology, scientists are continuously finding new ways to fight against infectious diseases. Two main types of anti-infectives are available: vaccines and antivirals.
Rapid Innovation in Vaccines
Vaccines are substances designed to prevent people from getting infected with a disease or experiencing serious symptoms.
The number of vaccines has increased dramatically over the last three decades. From 2020 to 2021 alone, the number of approved vaccines or clinical candidates jumped by 13%.
Year | Vaccines Approved or in Development |
---|---|
1995 | 240 |
1996 | 262 |
1997 | 309 |
1998 | 323 |
1999 | 374 |
2000 | 415 |
2001 | 462 |
2002 | 472 |
2003 | 509 |
2004 | 531 |
2005 | 564 |
2006 | 610 |
2007 | 606 |
2008 | 704 |
2009 | 751 |
2010 | 866 |
2011 | 893 |
2012 | 880 |
2013 | 943 |
2014 | 1075 |
2015 | 1179 |
2016 | 1374 |
2017 | 1397 |
2018 | 1340 |
2019 | 1356 |
2020 | 1388 |
2021 | 1567 |
Data is a snapshot in time and reflects all vaccines ever approved (and not taken off the market) plus all vaccines in development as of the noted year (for which a trial has not been canceled).
Not only that, it’s possible to have shorter approval timelines. COVID-19 vaccines were approved within 11 months, much more quickly than the 2000-2020 average of 10 years.
In the time between an outbreak and vaccine development, antivirals can play a vital role.
Antivirals: The Second Line of Defense in Virology
Antivirals are drugs that slow or prevent the growth of a virus and treat disease symptoms. They are especially important tools for diseases that do not have an associated vaccine.
In 2021, there were nearly six times as many approved antivirals as there were in 1995. Not only that, antiviral uses have grown to include the potential prevention and treatment of HIV, COVID-19, and a number of other diseases.
Year | Approved Antivirals in the U.S. | Reasons for Using Antivirals |
---|---|---|
1995 | 10 | 12 |
1996 | 10 | 12 |
1997 | 12 | 12 |
1998 | 13 | 13 |
1999 | 16 | 13 |
2000 | 18 | 13 |
2001 | 19 | 13 |
2002 | 20 | 13 |
2003 | 21 | 13 |
2004 | 21 | 13 |
2005 | 22 | 13 |
2006 | 23 | 13 |
2007 | 24 | 13 |
2008 | 26 | 13 |
2009 | 27 | 14 |
2010 | 27 | 14 |
2011 | 30 | 14 |
2012 | 30 | 15 |
2013 | 34 | 15 |
2014 | 37 | 15 |
2015 | 41 | 16 |
2016 | 44 | 16 |
2017 | 47 | 16 |
2018 | 49 | 17 |
2019 | 49 | 17 |
2020 | 53 | 19 |
2021 | 57 | 20 |
The potential prevention (prophylaxis) and treatment of the same virus are counted as separate uses. Data is cumulative and reflects all antivirals ever approved (and not taken off the market) and all reasons ever approved for using antivirals (that have not been rescinded).
Innovation in virology—and the potential for future developments—is leading to a growing industry.
Expanding Market Opportunities
With opportunities growing and approval times shortening, more companies are entering the market.
Year | Companies Developing Vaccines/Antivirals |
---|---|
1995 | 66 |
1996 | 73 |
1997 | 80 |
1998 | 81 |
1999 | 87 |
2000 | 111 |
2001 | 125 |
2002 | 140 |
2003 | 154 |
2004 | 144 |
2005 | 146 |
2006 | 163 |
2007 | 167 |
2008 | 196 |
2009 | 203 |
2010 | 230 |
2011 | 237 |
2012 | 255 |
2013 | 277 |
2014 | 289 |
2015 | 310 |
2016 | 362 |
2017 | 392 |
2018 | 374 |
2019 | 370 |
2020 | 383 |
2021 | 484 |
Data is a snapshot in time and reflects all companies developing vaccines or antivirals as of the noted year. If a company stops being active in the space or ceases to exist, they are removed from the total.
As they work to develop new vaccines and antivirals, companies are conducting clinical trials for many diseases beyond COVID-19 such as respiratory infections and sepsis.
Virology is leading to a number of groundbreaking technologies and therapies, transforming healthcare along the way.

Explore the MSCI Virology Index now.

-
Healthcare5 months ago
Ranked: The Best U.S. States for Retirement
Getting ready for retirement? See which states score the highest in terms of affordability, quality of life, and health care.
-
Politics6 months ago
Timeline: Cannabis Legislation in the U.S.
At the federal level, cannabis is illegal, but state laws differ. This graphic looks at the timelines of cannabis legislation in the U.S.
-
Science11 months ago
Visualizing the Composition of Blood
Despite its simple appearance, blood is made up of many microscopic elements. This infographic visualizes the composition of blood.
-
Science1 year ago
Visualizing the Relationship Between Cancer and Lifespan
New research links mutation rates and lifespan. We visualize the data supporting this new framework for understanding cancer.
-
Misc1 year ago
Explainer: What to Know About Monkeypox
What is monkeypox, and what risk does it pose to the public? This infographic breaks down the symptoms, transmission, and more.
-
Healthcare2 years ago
Visualizing How COVID-19 Antiviral Pills and Vaccines Work at the Cellular Level
Despite tackling the same disease, vaccines and antiviral pills work differently to combat COVID-19. We visualize how they work in the body.
-
Markets21 hours ago
Visualizing the Most Sought-After Entry Level Jobs in 2023
-
Money3 weeks ago
How Much Does it Take to Be Wealthy in America?
-
Markets2 weeks ago
Ranked: The Highest Paid CEOs in the S&P 500
-
Retail3 weeks ago
Visualizing the Number of Costco Stores, by Country
-
Markets1 week ago
Charted: Market Volatility at its Lowest Point Since 2020
-
Culture3 weeks ago
Ranked: Which Countries Drink the Most Beer?
-
Wealth1 week ago
Mapped: The Migration of the World’s Millionaires in 2023
-
Maps3 weeks ago
Mapped: The Deadliest Earthquakes of the 21st Century